Weigh Loss Jab Mounjaro: Benefits Reversed When Stopped
Researchers studying participants who stopped using the weight loss medication Mounjaro have found that not only do they regain weight, but also experience a reversal of other health benefits. The study, published in the journal Jama Internal Medicine, involved 308 participants with obesity or overweight and related health issues, who received tirzepatide for 36 weeks alongside diet and exercise support.
During this period, the group showed significant improvements in blood pressure, cholesterol levels, and blood glucose control. However, once they switched to a placebo, these benefits reversed, suggesting that losing weight on the medication wasn't just about shedding pounds β it was also about improving overall health markers.
Experts warn that stopping Mounjaro can have serious consequences, including an increased risk of hospitalization for heart failure or death from any cause. This is because the medication helps reduce blood pressure and "bad" cholesterol levels, which are major risk factors for cardiovascular disease.
The study's findings highlight the importance of long-term weight management through a combination of lifestyle changes and obesity medications. However, they also underscore the risks of relying on weight loss jabs to achieve health benefits β as soon as the medication is stopped, these gains can be reversed, leaving individuals vulnerable to the negative effects of excess weight.
Critics argue that taking weight-loss medications does not necessarily lead to healthier eating habits or regular exercise routines. Instead, it often creates a false sense of security, leading people to abandon their efforts when they stop using the medication.
The research also raises concerns about the impact of Mounjaro on pregnancy outcomes. Women who use weight loss jabs before becoming pregnant may be more likely to experience complications during pregnancy and childbirth, such as preterm delivery, gestational diabetes, and hypertensive disorders. However, it is essential to note that this association has not been proven conclusively, and further trials are needed to confirm the findings.
The study's authors emphasize the need for sustainable weight management strategies that prioritize lifestyle changes over quick fixes like medication. By adopting healthier habits and seeking support from healthcare professionals, individuals can achieve long-term health benefits without relying on stopgap solutions.
Researchers studying participants who stopped using the weight loss medication Mounjaro have found that not only do they regain weight, but also experience a reversal of other health benefits. The study, published in the journal Jama Internal Medicine, involved 308 participants with obesity or overweight and related health issues, who received tirzepatide for 36 weeks alongside diet and exercise support.
During this period, the group showed significant improvements in blood pressure, cholesterol levels, and blood glucose control. However, once they switched to a placebo, these benefits reversed, suggesting that losing weight on the medication wasn't just about shedding pounds β it was also about improving overall health markers.
Experts warn that stopping Mounjaro can have serious consequences, including an increased risk of hospitalization for heart failure or death from any cause. This is because the medication helps reduce blood pressure and "bad" cholesterol levels, which are major risk factors for cardiovascular disease.
The study's findings highlight the importance of long-term weight management through a combination of lifestyle changes and obesity medications. However, they also underscore the risks of relying on weight loss jabs to achieve health benefits β as soon as the medication is stopped, these gains can be reversed, leaving individuals vulnerable to the negative effects of excess weight.
Critics argue that taking weight-loss medications does not necessarily lead to healthier eating habits or regular exercise routines. Instead, it often creates a false sense of security, leading people to abandon their efforts when they stop using the medication.
The research also raises concerns about the impact of Mounjaro on pregnancy outcomes. Women who use weight loss jabs before becoming pregnant may be more likely to experience complications during pregnancy and childbirth, such as preterm delivery, gestational diabetes, and hypertensive disorders. However, it is essential to note that this association has not been proven conclusively, and further trials are needed to confirm the findings.
The study's authors emphasize the need for sustainable weight management strategies that prioritize lifestyle changes over quick fixes like medication. By adopting healthier habits and seeking support from healthcare professionals, individuals can achieve long-term health benefits without relying on stopgap solutions.